2021 Webinar: Challenges in NASH Clinical Trials
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Join the Nonalcoholic Fatty Liver Disease Special Interest Group in discussing the current challenges in histological assessment in NASH clinical trials. Presenters will also discuss how to implement hard outcomes in NASH clinical trials and the use non-invasive biomarkers as primary endpoints for drug approval.
Webinar hosted by the Nonalcoholic Fatty Liver Disease Special Interest Group on May 19, 2021.
Powered By